← Open Payments lookup

STEVEN KANFER: Open Payments

NPI 1740337039 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$723 in 32 payments from 10 companies in 2025. Trend: 2023 $652 · 2024 $238 · 2025 $723

Food & beverage: $723
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$234
Alkermes, Inc.5$103
Neurocrine BioSciences, Inc.3$92
Janssen Pharmaceuticals, Inc4$91
E.R. Squibb & Sons, L.L.C.3$66
Teva Pharmaceuticals USA, Inc.3$50
Otsuka America Pharmaceutical, Inc.2$41
Luye Pharma (USA) Ltd.1$24
Supernus Pharmaceuticals, Inc.1$17
Corium, LLC2$5

Products named: CAPLYTA, INGREZZA, INVEGA SUSTENNA, ARISTADA, COBENFY, ABILIFY ASIMTUFII, UZEDY, LYBALVI.

Industry payments across FL — which companies pay providers there.